Nature-inspired Blood Filtration
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
711
NCT01072682
Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure
Phase: N/A
Role: Lead Sponsor
Start: Feb 28, 2010
Completion: May 31, 2011
NCT01400893
Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Start: Aug 31, 2011
Completion: Sep 30, 2013
NCT04395911
Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections
Start: Sep 10, 2020
Completion: Jul 21, 2021
NCT04537975
C2Rx Hemofiltration Treatment in Severe or Critically Ill Adults With COVID-19
Start: Sep 15, 2020
Completion: Jan 15, 2021
NCT05758077
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
Start: Apr 17, 2023
Completion: Sep 30, 2026
NCT06517810
QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry
Start: Jul 19, 2024
Completion: May 31, 2026
NCT03836482
Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD
Start: Sep 30, 2025
Completion: Aug 31, 2027
Loading map...